Cellectis

Last updated: April 15, 2024

André Choulika, CEO and Founder
André Choulika, CEO and Founder
Country: France | Funding: $328.2M (+)

Website: http://www.cellectis.com/

Cellectis is a biopharmaceutical company that develops adoptive immunotherapies for cancer.